Structum capsules 500mg №20×3

NameStruktum caps 500mg in a blister in pack No. 12×5 Main active ingredientChondroitin sulfate Release formcapsules CompositionActive ingredient: Chondroitin sulfate sodium500.00mg %) Titanium dioxide (E171). about 2.24 mg (2%) Indigotine (E132). about 0.1014 mg (0.0905%) yellowish. 60 capsules in thermoformed PVC-PVDC/aluminium foil blisters covered with a layer of heat-sealed varnish. Each blister contains 20 capsules. Accordingly, 3 blisters are packed together with a leaflet in a cardboard box. Dosage 500 mg Pharmacological properties Drug for the treatment of osteoarthritis. Chondroitin-sulfuric acid is an integral component of the basic substance of bone and cartilage. Indications for use Symptomatic treatment with delayed action of osteoarthritis of the hip and knee joints. Contraindications Hypersensitivity to the active substance or any of the excipients listed in section 6.1. Children under 15 (due to lack of accurate data). Application during pregnancy and lactation Data on the use of Chondroitin sulfate in pregnant women are absent or limited (less than 300 pregnancies). Animal studies have shown no direct or indirect adverse effects on reproductive toxicity. As a precautionary measure, it is recommended to avoid the use of the drug during pregnancy Lactation It is not known whether Chondroitin sulfate and metabolites of the drug are excreted in breast milk. A risk to newborns and infants cannot be excluded. The drug should not be taken during breastfeeding. Fertility Animal studies do not show any effect on fertility. Dosing and Administration The drug should only be used in adults (over the age of 15 years). Capsules are taken orally. Capsules should be swallowed whole with a large glass of water. One 500 mg capsule twice a day, i.e. 1 g per day. Use in children: There are no data to support the use of chondroitin sulfate in children 0-18 years of age. Therefore, the use of chondroitin sulfate in children is not recommended. Side effects The table below shows the adverse effects observed in seven clinical studies, including a total of 2,244 patients, 1,154 of whom received the drug STRUKTUM. Adverse effects are presented according to the MedDRA system organ classification and are listed below as: very common (? 1/10), common (? 1/100 to < 1/10), less common (? 1/1000 to < 1/100) , rare (? 1/10000 to < 1/1000), very rare (< 1/10000), unknown (cannot be estimated from the available data). No "very rare" or "very common" adverse effect groups were observed, so these columns are not included in the table below. OFTEN ? 1% to 10% INFREQUENTLY ? 0.1% to 1% RARE < 0.1% 08 - Nervous system disorders dizziness 14 - Gastrointestinal disorders diarrhea, abdominal pain, nausea vomiting 16 - Skin and subcutaneous tissue disorders urticaria, pruritus - skin rash angioedema , erythema 22 - General disorders and disorders at the injection site swelling of the face Preferred terms are classified and grouped into high-level grouping terms (HLTL). Conditions for the same HLTV are separated by a '-'. SIDE EFFECT REPORTING If you have any adverse reactions, tell your doctor. This also applies to any adverse reactions not listed in this package insert. You can report adverse reactions to the information database on adverse reactions (actions) to drugs, including reports of ineffectiveness of drugs identified in the Republic of Belarus (UE Center for Expertise and Testing in Healthcare of the Ministry of Health of the Republic of Belarus, ). By reporting adverse reactions, you help to get more information about the safety of the drug. Overdose In case of overdose, symptomatic treatment is prescribed. Storage conditions Store at a temperature not exceeding 25 ° C, out of the reach of children. Buy Structum capsules 500mg No. 20x3 Price for Structum capsules 500mg No. 20x3